Time for a deep breath, page-7

Its all about perceptions and viewpoints.

Back in January/February 2015 our market cap was circa $300-$400M after the Abbvie announcement which only gave us a $5 million cash injection. At the time of the announcement we had $10 million cash in the bank, enough to keep the company going for 2-3 months.

Fast forward to now, we have Amgen and a capital injection, we are likely to get a CEO that has appropriate qualifications, discipline and experience. We have to be closer to production and revenue than we were back in Jan/Feb 2015. Yet our market cap is $47 million.

Is this a case of the share price over-shooting one way, and then to the other...